The SLC17A1 gene gives your kidneys instructions for a transporter that helps move uric acid and some other small molecules into urine. Differences in this gene can help explain why people have higher or lower uric acid levels. When this transporter works less well, uric acid may build up in the blood, which can raise the chance of gout and sometimes kidney stones.
What is a gene?
A gene is a stretch of DNA that gives your cells information they can use to make molecules or regulate processes in the body. Some genes carry the instructions for producing proteins, the parts of cells that do the work. Other genes mostly help direct when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
SLC17A1Gene function
What if the gene works
The SLC17A1 gene helps kidney cells move phosphate and uric acid into urine. This supports mineral balance and helps your body clear some waste products.
Risk
What if the gene does not work
Changes in the SLC17A1 gene can reduce how well kidney cells move urate and phosphate across their membranes. Milder variants may slightly alter transport, while more severe variants can cause a larger loss of this transporter activity.
Treatment
What does that mean for your treatment
No SLC17A1-specific treatment or drug choice approach is currently established in clinical guidelines. The SLC17A1 gene is being studied as part of kidney uric acid handling and as a possible biomarker for gout and urate levels, but this does not currently guide care.
Gene function
What if the gene works
Your kidneys use the SLC17A1 gene to move certain charged substances across kidney tubule cells. Its protein sits on the urine facing side of these cells, where it helps handle phosphate and urate. This day to day transport is a key part of what the SLC17A1 gene does in the kidney.
In kidney tubule cells, the SLC17A1 gene helps move phosphate across the cell surface using the natural sodium flow. This supports normal phosphate handling, which matters for bones, teeth, and how cells make and use energy.
This transporter also helps kidney cells pass urate, a natural waste product, toward the urine. That everyday step supports the body’s normal way of clearing some excess uric acid.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
SLC17A1 gene variants can change the shape, stability, or cell surface placement of this transporter, which may alter how kidney tubule cells move urate and other small charged molecules. Milder changes often slightly shift transport activity, while more severe variants can markedly reduce or abolish it, so the effect of SLC17A1 gene variants on urate transport can range from subtle to more pronounced.
How variants are linked to conditions
Common variants in the SLC17A1 gene are linked to differences in blood uric acid levels and to a person’s gout risk. In studies of the SLC17A1 gene and gout risk, some variants are associated with a lower chance of gout, while others are linked to a higher chance. These are population-level risk patterns, not a diagnosis on their own.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural variation among people. For many genes, a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences contribute. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC17A1, the clearest link is with uric acid levels and gout risk, and the gene is only one part of the picture. Risk can also rise with excess body weight, kidney problems, regular alcohol use, and a diet high in purines, such as large amounts of red meat and some seafood.
Inheritance of SLC17A1 variants
There is no broadly confirmed Mendelian pattern for inheritance of SLC17A1 gene variants tied to a specific single-gene condition. Instead, changes in the SLC17A1 gene are most often discussed as one factor among many that can influence traits such as uric acid handling, so inheritance of SLC17A1 gene variants does not follow a clearly established dominant or recessive pattern. The SLC17A1 gene is located on chromosome 6, which is an autosome, so you inherit one copy from each parent.
What does my SLC17A1 result mean for my family?
There is not yet a broadly confirmed family inheritance pattern tied to a specific health condition for the SLC17A1 gene, though this can become clearer as research grows. If you have a specific SLC17A1 result, a doctor or genetic counselor can explain what it may mean for close relatives based on the exact change that was found.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLC17A1 variants uses a blood sample, cheek swab, or saliva sample to read the DNA in the SLC17A1 gene. Labs usually analyze this gene as part of a multigene panel or broader sequencing test and report whether a variant was found, along with how clearly its health meaning is understood.
When should I consider getting a genetic test?
There is not yet a broadly established, SLC17A1-specific clinical reason for genetic testing in routine care. Testing decisions are usually best made with a doctor or genetic counselor, based on your personal health history, family history, and the reason for testing.
A genetic result is only one part of your health story
Genetic results can provide valuable insight, but what they can tell you varies with the condition and the specific type of variant. Lifestyle, environment, age, and medical history are among the many factors that influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, these results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. These differences are common and are one part of why medication response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences affect how people respond to medicines. It studies the links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are both better informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the SLC17A1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so general questions about medicines, side effects, or your health are best discussed with your doctor. Seek medical advice if a treatment is not working as expected or you develop new symptoms after starting a medicine.
History
SLC17A1 first drew attention when researchers studying kidney transport proteins identified it as a sodium phosphate transporter, often called NPT1. Initially understood only through visible traits, later recognized as tied to a specific gene, its story shifted as laboratory work clarified where it is active and how it moves small molecules. From these first observations, research expanded steadily, and scientists began linking common variants in the SLC17A1 gene to differences in uric acid handling. That connection brought the gene into studies of gout and kidney health, especially through large genetic studies in the 2000s and 2010s. Over time, the SLC17A1 gene became better known as part of the broader picture of how the body manages urate.